127 related articles for article (PubMed ID: 8643096)
1. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
Gobbi M; Parotti L; Mennini T
Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
[TBL] [Abstract][Full Text] [Related]
2. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
Sleight AJ; Carolo C; Petit N; Zwingelstein C; Bourson A
Mol Pharmacol; 1995 Jan; 47(1):99-103. PubMed ID: 7838138
[TBL] [Abstract][Full Text] [Related]
3. Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors.
Clemett DA; Kendall DA; Cockett MI; Marsden CA; Fone KC
Br J Pharmacol; 1999 May; 127(1):236-42. PubMed ID: 10369478
[TBL] [Abstract][Full Text] [Related]
4. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
Shimizu M; Nishida A; Zensho H; Yamawaki S
J Pharmacol Exp Ther; 1996 Dec; 279(3):1551-8. PubMed ID: 8968382
[TBL] [Abstract][Full Text] [Related]
5. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
[TBL] [Abstract][Full Text] [Related]
6. Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine.
Stowe RL; Barnes NM
Neuropharmacology; 1998 Dec; 37(12):1611-9. PubMed ID: 9886684
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
[TBL] [Abstract][Full Text] [Related]
8. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
9. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
Langer SZ; Moret C
J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
[TBL] [Abstract][Full Text] [Related]
10. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
11. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
12. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
Nelson DL; Pedigo NW; Yamamura HI
J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
[TBL] [Abstract][Full Text] [Related]
13. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
15. Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine.
Kitazawa T; Kubo O; Satoh M; Taneike T
Br J Pharmacol; 1998 Jan; 123(2):173-82. PubMed ID: 9489604
[TBL] [Abstract][Full Text] [Related]
16. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
Sills MA; Wolfe BB; Frazer A
Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
[TBL] [Abstract][Full Text] [Related]
17. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
18. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
[TBL] [Abstract][Full Text] [Related]
20. Effect of methiothepin on imipramine- or mianserin- induced subsensitivity of serotonergic receptors.
Segawa T; Uehara M
Life Sci; 1982 Mar; 30(10):809-12. PubMed ID: 7070196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
